Corline Biomedical AB Financial Overview
Corline Biomedical AB's market cap is currently kr416.34M. The company's EPS TTM is kr-0.137; its P/E ratio is -16.66; Corline Biomedical AB is scheduled to report earnings on November 18, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
